StockData
ENDRA Life Sciences Inc. logo

ENDRA Life Sciences Inc. (NDRA) stock

NDRANasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$4.04+0.12 (+2.93%)

Close on Nov 18, 2026Market cap $6.05MP/E –Yield –

ENDRA Life Sciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

ENDRA Life Sciences's price to book ratio was 1.1× on Nov 11, 2026, against 27.1× a year earlier. Over the last 3 years it ranged from 0.4× to 408.0×, with a median of 2.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.1×−19.7
2025Dec 31, 202520.8×+20.3
2024Dec 31, 20240.5×–

More ENDRA Life Sciences figures

See a number that looks wrong?